Speciation 98: Abstracts
Malgorzata Jezowska-Bojczuk
Faculty of Chemistry, University of Wroclaw, 50-383 Wroclaw, Poland
Aminoglycoside antibiotics play an important role in modern therapy, ranging from household skin ointments to general sepsis treatments in intensive therapy wards. They are very efficient against a broad range of bacterial pathogens. Their usage is limited, however, by very narrow windows of therapeutical concentrations and severe oto- and nephrotoxicity when threshold concentrations are exceeded.
Molecules of aminoglycosides are a combination of aminosugar and aminocyclitol rings. They usually contain 4-6 amino groups, which are essential for their biological activities. Our previous studies 1 indicated that aminosugars are very good {N,O} ligands for Cu(II) ions. We also provided evidence that such co-ordination results in strong oxygen activation. 2 Having these results in mind, we performed studies of Cu(II) binding by several aminoglycosides 3-6 and investigated the oxygen activation using 2'-deoxyguanosine as reporter molecule. 3,4 The results of these studies can be summarised as follows:
(i) unsubstituted aminoglycosides 4-6 use aminosugar-like
{N,O}chelates to bind Cu(II), despite the presence of a pair of
suitably located amino groups in their deoxystreptamine (B) ring.
However, amidation of one of these nitrogens in amikacin 3
makes B ring the sole binding site;
(ii) the C-ring is the anchoring
site for Cu(II) in unsubstituted aminoglycosides at pH 5-6. At
higher pH the A-ring donors participate in the binding of the
same Cu(II) ion, forming a macrochelate assembly;
(iii) oxygen
activation is a common feature of Cu(II) complexes of aminoglycosides.
2-4 These properties, together with model biospeciation
studies performed for amikacin,3 suggest that the Cu(II)
binding may be an element of bioactivity of aminoglycosides.
References